A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis

Abstract Introduction Ivacaftor (IVA) has been shown to change the trajectory of cystic fibrosis (CF) disease progression by slowing the rate of lung function decline in clinical studies. Long-term real-world data help to confirm the durability of this response. Methods This non-interventional, long...

Cijeli opis

Bibliografski detalji

Glavni autori:	Christian Merlo, Teja Thorat, Lisa J. McGarry, Christina V. Scirica, Maral DerSarkissian, Catherine Nguyen, Yuqian M. Gu, Aruna Muthukumar, Joe Healy, Jaime L. Rubin, M. Alan Brookhart
Format:	Artigo
Jezik:	Inglês
Izdano:	Adis, Springer Healthcare 2024-09-01
Serija:	Pulmonary Therapy
Teme:	CFTR modulator Cystic fibrosis Disease trajectory Ivacaftor Longitudinal study Lung function decline
Online pristup:	https://doi.org/10.1007/s41030-024-00269-9
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!